The ASI Evolution facilitates laboratories’ use of CDC’s traditional nontreponemal screening algorithm with a fully automated assay that increases efficiency and output.
Read More
A bedside test identifies infants with a genetic mutation of the mitochondrial DNA responsible for irreversible hearing loss as an adverse reaction to the antibiotic gentamicin.
Read More
New applications include customizable QIAact target enrichment panels for next-generation sequencing of more than 13 hereditary disease groups.
Read MoreThe partners’ workflow will enable researchers to analyze single-cell data easily, without any prior bioinformatics knowledge.
Read More
The PanFAM-1 study is designed to validate Immunovia’s IMMray PanCan-d assay, the first blood-based test for early detection of pancreatic cancer.
Read More